Norman Lattimer

508 total citations · 1 hit paper
17 papers, 412 citations indexed

About

Norman Lattimer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Norman Lattimer has authored 17 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Norman Lattimer's work include Receptor Mechanisms and Signaling (6 papers), Neuroendocrine regulation and behavior (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Norman Lattimer is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuroendocrine regulation and behavior (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Norman Lattimer collaborates with scholars based in United Kingdom. Norman Lattimer's co-authors include John R. Vane, Salvador Moncada, J. M. Armstrong, John F. Waterfall, James L. J. Coleman, Sourabh Sharma, Christine Ennis, G. J. Dusting, G Dover and M. C. W. Minchin and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Journal of Pharmacy and Pharmacology.

In The Last Decade

Norman Lattimer

17 papers receiving 358 citations

Hit Papers

COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN A... 1978 2026 1994 2010 1978 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norman Lattimer United Kingdom 8 167 150 116 95 91 17 412
K. McKechnie United Kingdom 12 242 1.4× 76 0.5× 94 0.8× 155 1.6× 53 0.6× 17 652
Robert Gaudet United States 5 207 1.2× 121 0.8× 141 1.2× 178 1.9× 172 1.9× 5 613
Motohiko Ueda Japan 12 222 1.3× 57 0.4× 103 0.9× 142 1.5× 40 0.4× 52 472
Masaki Shibota Japan 12 163 1.0× 35 0.2× 82 0.7× 97 1.0× 39 0.4× 27 372
Norman R. Eade Canada 10 142 0.9× 54 0.4× 68 0.6× 73 0.8× 40 0.4× 19 512
G B Weiss United States 12 268 1.6× 38 0.3× 105 0.9× 166 1.7× 65 0.7× 20 483
John F. Reed United States 14 228 1.4× 105 0.7× 238 2.1× 122 1.3× 84 0.9× 18 752
Hideto Miyazaki Japan 10 140 0.8× 107 0.7× 54 0.5× 42 0.4× 25 0.3× 24 365
Minoru Ohtsuka Japan 10 157 0.9× 63 0.4× 70 0.6× 106 1.1× 18 0.2× 29 372
R.A. Podevin France 15 392 2.3× 32 0.2× 166 1.4× 68 0.7× 62 0.7× 23 608

Countries citing papers authored by Norman Lattimer

Since Specialization
Citations

This map shows the geographic impact of Norman Lattimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Lattimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Lattimer more than expected).

Fields of papers citing papers by Norman Lattimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Lattimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Lattimer. The network helps show where Norman Lattimer may publish in the future.

Co-authorship network of co-authors of Norman Lattimer

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Lattimer. A scholar is included among the top collaborators of Norman Lattimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Lattimer. Norman Lattimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lattimer, Norman, et al.. (1993). Characterization of the 5‐hydroxytryptamine receptor mediating the positive inotropic response in guinea‐pig isolated left atria. British Journal of Pharmacology. 109(4). 1192–1195. 4 indexed citations
2.
Dover, G, et al.. (1993). The antagonist actions of WAY 100135 and its enantiomers on 5-HT1A receptor-mediated hyperpolarization of the rat isolated superior cervical ganglion. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(3). 225–7. 5 indexed citations
3.
Middlefell, Vicki C., et al.. (1993). WAY 100289: Pharmacological profile of a novel 5‐HT3 receptor antagonist. Drug Development Research. 28(2). 128–140. 7 indexed citations
4.
Coleman, James L. J., et al.. (1992). A component of 5-HT-evoked depolarization of the rat isolated vagus nerve is mediated by a putative 5-HT4 receptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(5). 496–503. 39 indexed citations
5.
Minchin, M. C. W., et al.. (1992). The GABAA-like autoreceptor is a pharmacologically novel GABA receptor.. PubMed. 47. 199–203. 3 indexed citations
6.
Warrellow, Graham J., et al.. (1989). Synthesis and .alpha.2-adrenoceptor antagonist activity of some disulfonamidobenzoquinolizines. Journal of Medicinal Chemistry. 32(1). 179–182. 5 indexed citations
7.
Lattimer, Norman, et al.. (1988). Synthesis and structure-activity relationships of 2-sulfonamido-1,3,4,6,7,11b.alpha.-hexahydro-2H-benzo[a]quinolizines as .alpha.2-adrenoceptor antagonists. Journal of Medicinal Chemistry. 31(7). 1421–1426. 10 indexed citations
8.
Ennis, Christine, et al.. (1986). Can the effects of meptazinol on the guinea-pig isolated ileum be explained by inhibition of acetylcholinesterase?. Journal of Pharmacy and Pharmacology. 38(1). 24–27. 13 indexed citations
9.
Lattimer, Norman, et al.. (1986). Some pharmacological properties of Wy 27127 a more selective alpha2: alpha1-adrenoceptor antagonist than idazoxain in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 334(4). 418–422. 3 indexed citations
10.
Waterfall, John F., et al.. (1985). Studies of α2-adrenoceptor antagonist potency in vitro: comparisons in tissues from rats, rabbits, dogs and humans. Clinical Science. 68(s10). 21s–24s. 22 indexed citations
11.
Lattimer, Norman, et al.. (1985). A difference in the affinity of some selective ?2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit. Naunyn-Schmiedeberg s Archives of Pharmacology. 329(3). 278–281. 25 indexed citations
12.
Lattimer, Norman, et al.. (1984). Alpha2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 327(4). 312–318. 39 indexed citations
13.
Ennis, Christine & Norman Lattimer. (1984). Presynaptic agonist effect of phentolamine in the rabbit vas deferens and rat cerebral cortex. Journal of Pharmacy and Pharmacology. 36(11). 753–757. 4 indexed citations
14.
Armstrong, J. M., Norman Lattimer, Salvador Moncada, & John R. Vane. (1978). COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITS. British Journal of Pharmacology. 62(1). 125–130. 222 indexed citations breakdown →
15.
Dusting, G. J., Norman Lattimer, Salvador Moncada, & John R. Vane. (1977). Prostaglandin X, the vascular metabolite of arachidonic acid responsible for relaxation of bovine coronary artery strips [proceedings].. PubMed. 59(3). 443P–443P. 8 indexed citations
16.
Armstrong, J. M. & Norman Lattimer. (1976). Prostaglandin E2 released from the kidneys of genetic hypertensive rats contributes to the vasoconstrictor supersensitivity to angiotensin II in vitro [proceedings].. PubMed. 58(3). 462P–462P. 2 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026